JFL Life Sciences Ltd (JFLLIFE) is currently trading at 10.30 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

JFL Life Sciences Limited manufactures and markets pharmaceutical products, with core focus on dry powder injections, B‑lactam tablets and capsules, general solid oral dosage forms and oral rehydration solutions (ORS); the company operates manufacturing facilities in Ahmedabad and exports products to Africa, Middle East and select CIS markets through merchant exporters and registered product approvals. The company completed conversion from private to public in 2022 and completed an IPO in August 2022 raising approximately Rs. 18.16 crore; that capital event formally broadened public ownership but the presentation shows no clear large-scale follow‑on capex or greenfield capacity announcements since the IPO, suggesting growth remains organically driven and export led. The Board approved unaudited financial results for the quarter and nine months ended December 31, 2025, and a statutory limited review was issued by the external auditors who reported no matters causing them to believe the interim statements were materially misstated; the filing confirms continuing regulatory compliance and timely board oversight of quarterly reporting. Operational controls emphasize batch identification, quarantining after key manufacturing stages, QA clearance before progression, and labeled containers under test; the company holds MOH registrations in Kenya, Nigeria, Yemen, Cambodia and Myanmar, while some products are registered in CIS jurisdictions, highlighting export market focus and regulatory dependency with potential concentration and merchant‑export channel risk.

Over the past 52 weeks, JFL Life Sciences Ltd has traded between a low of ₹8.55 and a high of ₹14.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

JFL Life Sciences Ltd has a market capitalization of approximately 33.99. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

JFL Life Sciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 5.03 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 33.99 Cr, JFL Life Sciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

JFL Life Sciences Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of JFL Life Sciences Ltd is 5.03. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.